Statement about NICE decision on T-VEC for treating inoperable metastatic melanoma | The Royal Marsden
Scientific Lecture | Kevin Harrington | FRONTAL
Oracle Research Event 2019 Kevin Harrington: Radiotherapy - YouTube
High-tech radiotherapy, drug combinations and immunotherapy showcased as future of cancer treatment - The Institute of Cancer Research, London
Using Viruses to Treat Cancer | Prof Kevin Harrington | #SCIPEL 2015 | SCI - YouTube
The ICR on Twitter: "Professor Kevin Harrington specialises in #HeadAndNeckCancer. He and his team study the use of biologically targeted agents, in combination with treatments such as #Radiotherapy and #Chemotherapy, to target #
The ICR on Twitter: "🧬 The ICR's Professor Kevin Harrington and his team are using viral #Immunotherapy to harness the body's immune system to kill cancer. See their research with T-VEC, a
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London
Professor Kevin Harrington - YouTube
Higher Scientific Officer - Targeted Therapy Team, Prof Kevin Harrington (ID496) at The Institute of Cancer Research
Connections blog - ICR celebrates innovation and commercialisation at staff awards - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London
The Institute of Cancer Research - Professor Kevin Harrington (ICR + Royal Marsden NHS Foundation Trust) responds to today's news of the 2018 Nobel Prize for Physiology or Medicine being awarded to
The ICR on Twitter: "Watch Professor Kevin Harrington on @BBCLondonNews as he shares more on how a modified version of the herpes virus could offer hope for some people with advanced #Cancer.
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
The ICR on Twitter: "ICR's Professor Kevin Harrington speaks about the @NICEcomms news about immunotherapy #nivolumab https://t.co/pRd7KUmAmR #CancerDrugsFund https://t.co/ompikxJVHr" / Twitter
BBC Two - Trust Me, I'm a Doctor, Series 3, Episode 3 - Could viral immunotherapy be a revolution in cancer treatment?
Professor Kevin Harrington | The Royal Marsden
Connections blog - ICR celebrates innovation and commercialisation at staff awards - The Institute of Cancer Research, London
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
Using imaging to predict and improve responses to immunotherapy - Oracle Cancer Trust
The ICR on Twitter: "Professors Kevin Harrington and Alan Melcher (ICR + @royalmarsdenNHS) featured earlier in a @BBCr4today segment on #immunotherapy. In the UK you can still listen to today's live program
